A detailed history of New Covenant Trust Company, N.A. transactions in Johnson & Johnson stock. As of the latest transaction made, New Covenant Trust Company, N.A. holds 3,855 shares of JNJ stock, worth $555,197. This represents 0.6% of its overall portfolio holdings.

Number of Shares
3,855
Previous 3,878 0.59%
Holding current value
$555,197
Previous $600 Million 3.72%
% of portfolio
0.6%
Previous 0.69%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $3,346 - $3,849
-23 Reduced 0.59%
3,855 $622 Million
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $30,031 - $32,818
-208 Reduced 5.09%
3,878 $600 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $634,228 - $664,955
4,086 New
4,086 $646,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $377B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track New Covenant Trust Company, N.A. Portfolio

Follow New Covenant Trust Company, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Covenant Trust Company, N.A., based on Form 13F filings with the SEC.

News

Stay updated on New Covenant Trust Company, N.A. with notifications on news.